Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Cell Source, Inc. (CLCS) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/21/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
03/11/2022 8-K Quarterly results
04/01/2021 8-K Quarterly results
04/19/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/16/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release"
11/05/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative November 4, 2015 -- Cell Source, Inc. a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced their initiative for joint venture Pharma collaborations at their inaugural Scientific Advisory Board Summit held in New York City. SAB members are leading experts from Harvard University, Stanford University, Oxford University, Mt. Sinai Medical and University Hospital Wurzburg. They have endorsed Cell Source’s pursuit of JV collaborations with major Pharma players. Recent scientific developments and new provisional patent applications have set the stage for these JV Pharma Collaborations to leverage Cell Source’s Veto Cell technology and accelera..."
08/19/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cell Source Appoints Dr. Dennis Brown as Chairman of its Board of Directors New York, NY, August 19th, 2015 -- Cell Source, Inc. a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Dennis Brown, currently a Director of Cell Source, has been appointed Chairman of the Board of Directors. Itamar Shimrat, CEO of Cell Source stated “Dr. Brown’s proven track record of developing and commercializing pharmaceutical products and his past experience as an inventor, executive and chairman of biopharmaceutical companies positions him well to lead Cell Source as it makes significant strides towards commercializing its technology. Dr. Brown, who joined our Board last year, has become both a thought leader and ac..."
07/28/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Zolty Promissory Note",
"Zolty Warrant",
"Form of Convertible Promissory Note",
"Form of Warrant"
06/10/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Consulting/Advisory Agreement",
"Cell Source Appoints Dr. Terry Strom as Chairman of Its Scientific Advisory Board"
06/03/2015 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Agreement",
"Form of Note",
"Form of Warrant"
05/28/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CLCS Presentation at Marcum MicroCap Conference 2015"
04/01/2015 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
Docs: "Form of Promissory Notes",
"Form of Warrants"
12/02/2014 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "Form of Promissory Note"
07/01/2014 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Share Exchange Agreement, by and between Cell Source, Ltd., and Ticket to See, Inc",
"Articles of Association of Cell Source Limited, as amended on November 11, 2013",
"Form of Subscription Agreement",
"Form of Registration Rights Agreement",
"Form of Investor Warrant",
"Form of Researcher Company Warrant",
"Form of Company Warrant",
"Research and License Agreement by and between Yeda Research and Development Company Limited and Cell Source Limited",
"Amendment to Research and License Agreement",
"Amendment to Evaluation and Exclusive Option Agreement by and between Yeda Research and Development Company Limited and Cell Source Limited"
06/30/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Consulting Agreement",
"Form of Warrant"
06/26/2014 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to Articles of Incorporation"
06/06/2014 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to Articles of Incorporation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy